title: [Hepatorenal syndrome - pathophysiology, diagnosis and treatment].
abstract: Hepatorenal syndrome (HRS) is a life-treating complication of liver diseases. This functional kidney impairment is classified into acute (type I) and chronic (type II) types and is connected with high mortality. Treatment options are limited, but administration of vasoconstrictors (terlipressin), albumin and portosystemic shunt may improve their prognosis. Liver transplantation is the most effective method for these patients. Authors want to present recent data relating to HRS, including therapeutic recommendations.
authors.forename: Vladimír
authors.initials: V
authors.lastname: Hrabovský
authors.forename: Alice
authors.initials: A
authors.lastname: Mendlová
authors.forename: Terezie
authors.initials: T
authors.lastname: Vavříčková
mesh_terms: D006530:Hepatorenal Syndrome / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy*; D006801:Humans; D016031:Liver Transplantation; D008236:Lypressin / Q000031:analogs & derivatives / Q000627:therapeutic use; D011170:Portasystemic Shunt, Surgical; D011379:Prognosis; D000077585:Terlipressin; D014662:Vasoconstrictor Agents / Q000627:therapeutic use
chemical_list: D014662:Vasoconstrictor Agents; D008236:Lypressin; D000077585:Terlipressin